Stay updated on Amivantamab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Colorectal Cancer Clinical Trial page.

Latest updates to the Amivantamab in Colorectal Cancer Clinical Trial page
- Check5 days agoChange DetectedA notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears above the site navigation, and the displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, rendering the study record inaccessible.SummaryDifference20%

- Check40 days agoChange DetectedUI text for locating the study contact information was updated from 'Find Contact Information' to 'Find contact information'. The revision label shows 'Revision: v3.7.0', replacing the old 'Revision: v3.6.6'.SummaryDifference0.1%

- Check54 days agoChange DetectedA Madrid site entry was added with postal code 28009, and the Madrid site at 28007 was removed; the page revision was updated to v3.6.6 with the corresponding dates (2026-08-28 addition, 2026-08-27 update).SummaryDifference0.2%

- Check61 days agoChange DetectedA new line '2023 ( U.S. NIH Grant/Contract )' was added, indicating NIH funding for the study. This adds funding attribution to the record without changing the study design or eligibility.SummaryDifference0.0%

Stay in the know with updates to Amivantamab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Colorectal Cancer Clinical Trial page.